$LOAN
Manhattan Bridge Capital Inc Stock $loan

$loan Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000114420413042077 Filed on July 31, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$553.8K	$414.6K
YoY Change	33.59%	21.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$200.0K	$200.0K
YoY Change	0.0%	5.26%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$210.0K	$200.0K
YoY Change	5.0%	5.26%
Operating Profit	$247.0K	$157.9K
YoY Change	56.46%
Interest Expense	-$100.0K	-$60.00K
YoY Change	66.67%	50.0%
% of Operating Profit	-40.48%	-38.0%
Other Income/Expense, Net	$10.00K	$10.00K
YoY Change	0.0%	-66.67%
Pretax Income	$253.9K	$164.8K
YoY Change	54.1%	17.7%
Income Tax	$96.00K	$84.70K
% Of Pretax Income	37.81%	51.4%
Net Earnings	$157.9K	$80.08K
YoY Change	97.22%	-11.02%
Net Earnings / Revenue	28.52%	19.32%
Basic Earnings Per Share	$0.04	$0.02
Diluted Earnings Per Share	$0.04	$0.02
COMMON SHARES
Basic Shares Outstanding	4.275M shares	4.324M shares
Diluted Shares Outstanding	4.289M shares	4.331M shares

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.090M	$170.0K
YoY Change	541.18%	1600.0%
Cash & Equivalents	$1.094M	$166.5K
Short-Term Investments
Other Short-Term Assets	$51.11K	$50.00K
YoY Change	2.21%	0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$12.10M	$6.870M
YoY Change	76.07%	-25.41%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$250.0K	$250.0K
YoY Change	0.0%	-67.95%
Other Assets	$20.00K	$70.00K
YoY Change	-71.43%	-36.36%
Total Long-Term Assets	$3.665M	$4.850M
YoY Change	-24.44%	400.0%
TOTAL ASSETS
Total Short-Term Assets	$12.10M	$6.870M
Total Long-Term Assets	$3.665M	$4.850M
Total Assets	$15.76M	$11.72M
YoY Change	34.47%	15.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.00K	$20.00K
YoY Change	0.0%	-60.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.159M	$2.640M
YoY Change	-56.08%	94.12%
Long-Term Debt Due	$5.500M
YoY Change
Total Short-Term Liabilities	$7.038M	$2.930M
YoY Change	140.21%	71.35%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$500.0K
YoY Change	-100.0%	0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$500.0K
YoY Change	-100.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.038M	$2.930M
Total Long-Term Liabilities	$0.00	$500.0K
Total Liabilities	$7.040M	$3.430M
YoY Change	105.25%	55.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$654.3K
YoY Change
Common Stock	$9.723M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$346.0K
YoY Change
Treasury Stock Shares	163.0K shares
Shareholders Equity	$8.722M	$8.290M
YoY Change
Total Liabilities & Shareholders Equity	$15.76M	$11.72M
YoY Change	34.47%	15.13%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	$157.9K	$80.08K
YoY Change	97.22%	-11.02%
Depreciation, Depletion And Amortization	$0.00	$0.00
YoY Change
Cash From Operating Activities	$270.0K	$50.00K
YoY Change	440.0%	-68.75%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.650M	-$1.130M
YoY Change	46.02%	34.52%
Cash From Investing Activities	-$1.650M	-$1.130M
YoY Change	46.02%	34.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.230M	1.210M
YoY Change	84.3%	163.04%
NET CHANGE
Cash From Operating Activities	270.0K	50.00K
Cash From Investing Activities	-1.650M	-1.130M
Cash From Financing Activities	2.230M	1.210M
Net Change In Cash	850.0K	130.0K
YoY Change	553.85%	-159.09%
FREE CASH FLOW
Cash From Operating Activities	$270.0K	$50.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4405190	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4270190	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4298059	shares
CY2013Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	163000	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	107131	shares
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1094373	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240693	USD
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4433190	shares
	dei	Trading Symbol TradingSymbol	loan
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4267190	shares
	dei	Entity Registrant Name EntityRegistrantName	MANHATTAN BRIDGE CAPITAL, INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001080340
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2013Q2	loan	Short Term Loans Receivable ShortTermLoansReceivable	10790000	USD
CY2012Q4	loan	Short Term Loans Receivable ShortTermLoansReceivable	11022866	USD
CY2013Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	160418	USD
CY2013Q2	us-gaap	Other Assets Current OtherAssetsCurrent	51105	USD
CY2013Q2	loan	Investment In Real Estate InvestmentInRealEstate	146821	USD
CY2013Q2	loan	Long Term Loans Receivable LongTermLoansReceivable	3393000	USD
CY2013Q2	us-gaap	Security Deposit SecurityDeposit	6491	USD
CY2012Q4	us-gaap	Security Deposit SecurityDeposit	6491	USD
CY2013Q2	us-gaap	Cost Method Investments CostMethodInvestments	100000	USD
CY2012Q4	us-gaap	Cost Method Investments CostMethodInvestments	100000	USD
CY2013Q2	loan	Deferred Finance Costs DeferredFinanceCosts	18197	USD
CY2012Q4	loan	Deferred Finance Costs DeferredFinanceCosts	41735	USD
CY2013Q2	us-gaap	Senior Notes Current SeniorNotesCurrent	500000	USD
CY2012Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	500000	USD
CY2013Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19766	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	70403	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	12095896	USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	loan	Origination Fees OriginationFees	106273	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	253931	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	352246	USD
CY2012Q2	loan	Interest Income From Loans InterestIncomeFromLoans	332462	USD
	loan	Interest Income From Loans InterestIncomeFromLoans	892301	USD
CY2012Q2	loan	Origination Fees OriginationFees	82099	USD
	loan	Origination Fees OriginationFees	195855	USD
	loan	Origination Fees OriginationFees	166323	USD
CY2013Q2	us-gaap	Revenues Revenues	553795	USD
	us-gaap	Revenues Revenues	806387	USD
CY2013Q2	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	101560	USD
	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	100074	USD
CY2013Q2	loan	Referral Fees ReferralFees	334	USD
	loan	Referral Fees ReferralFees	3659	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	204857	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	364182	USD
CY2013Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	306751	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	467915	USD
CY2013Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6887	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	13774	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	247044	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	338472	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	96000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	157200	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	157931	USD
	us-gaap	Net Income Loss NetIncomeLoss	195046	USD
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4274562	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4324459	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4289134	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4332322	shares
CY2012Q2	us-gaap	Revenues Revenues	414561	USD
	us-gaap	Revenues Revenues	1088156	USD
CY2012Q2	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	58932	USD
	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	204206	USD
CY2012Q2	loan	Referral Fees ReferralFees	1530	USD
CY2012Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	160342	USD
	dei	Document Type DocumentType	10-Q
	loan	Share Based Compensation Expense ShareBasedCompensationExpense	8518	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	200730	USD
	us-gaap	Interest Paid InterestPaid	79206	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	18903	USD
CY2013Q2	us-gaap	Assets Assets	15760405	USD
CY2012Q4	loan	Investment In Real Estate InvestmentInRealEstate	146821	USD
CY2012Q4	loan	Long Term Loans Receivable LongTermLoansReceivable	2601500	USD
CY2012Q4	us-gaap	Assets Assets	14339351	USD
CY2013Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1159465	USD
CY2012Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1399465	USD
CY2013Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5000000	USD
CY2012Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	3500000	USD
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	11442804	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	4433	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	4405	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9718188	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9687159	USD
CY2013Q2	us-gaap	Treasury Stock Value TreasuryStockValue	346025	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	269972	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-654323	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-942607	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	8722273	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	8478985	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15760405	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14339351	USD
CY2013Q2	loan	Deferred Origination Fees DeferredOriginationFees	176765	USD
CY2012Q4	loan	Deferred Origination Fees DeferredOriginationFees	122242	USD
CY2013Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	182136	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	268256	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7038132	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5860366	USD
CY2013Q2	loan	Interest Income From Loans InterestIncomeFromLoans	447522	USD
	loan	Interest Income From Loans InterestIncomeFromLoans	640064	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4289988	shares
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
	loan	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	23538	USD
	loan	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	4843	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	0	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	322	USD
	loan	Share Based Compensation Expense ShareBasedCompensationExpense	7730	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	9574	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	32202	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	33376	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-50638	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-35441	USD
	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	-54523	USD
	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	-29940	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-86120	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-43530	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	248613	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	115960	USD
	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	8430500	USD
	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	5896000	USD
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	7871866	USD
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	4244641	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-558634	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1651359	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	70000	shares
	loan	Referral Fees ReferralFees	929	USD
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	196206	USD
CY2012Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	256668	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	582860	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	157893	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	505296	USD
CY2012Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6887	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	13774	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	377725	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	164780	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	519070	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	84700	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	188000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	80080	USD
	us-gaap	Net Income Loss NetIncomeLoss	331070	USD
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4324459	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4278868	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4331140	shares
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	76	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1163701	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1480000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	853680	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-55399	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	221905	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	166506	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	274120	USD
	us-gaap	Interest Paid InterestPaid	180667	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	42786	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	22540	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	USD
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	76053	USD
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	USD
	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	1260000	USD
	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	1480000	USD
CY2013Q2	loan	Jointly Funded Loans Total JointlyFundedLoansTotal	2385000	USD
CY2013Q2	loan	Jointly Funded Loans JointlyFundedLoans	1635000	USD
	loan	Long Term Loans Receivable Repayments In Five Years LongTermLoansReceivableRepaymentsInFiveYears	53000	USD
CY2013Q2	loan	Commercial Loans Issued To Borrowers CommercialLoansIssuedToBorrowers	3195000	USD
CY2013Q2	loan	Aggregate Percentage Of Commercial Loans Issued AggregatePercentageOfCommercialLoansIssued	0.225	pure
CY2013Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount Commercial LoansAndLeasesReceivableGrossCarryingAmountCommercial	14183000	USD
CY2012Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount Commercial LoansAndLeasesReceivableGrossCarryingAmountCommercial	11065710	USD
CY2013Q2	loan	Additional Construction Loan For Borrowers Subject To Conditions AdditionalConstructionLoanForBorrowersSubjectToConditions	2467950	USD
	loan	Fees Generated From Seller Buy Back Options FeesGeneratedFromSellerBuyBackOptions	13774	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	273880	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	343137	shares
CY2013Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	14572	shares
CY2012Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6681	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11120	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	7863	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	355000	shares
CY2011Q1	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	675000	USD
CY2011Q1	loan	Option Sold OptionSold	3900	USD
CY2011Q1	loan	Option Monthly Fee OptionMonthlyFee	10530	USD
CY2011Q4	loan	Exercise Price Of Remaining Property ExercisePriceOfRemainingProperty	146821	USD
	loan	Amortization Of Senior Secured Notes Issuance Cost AmortizationOfSeniorSecuredNotesIssuanceCost	18197	USD
CY2011Q4	loan	Monthly Option Fee For Property After Partial Exercise Of Option MonthlyOptionFeeForPropertyAfterPartialExerciseOfOption	2296	USD
	loan	Fees Generated From Seller Buy Back Options FeesGeneratedFromSellerBuyBackOptions	13774	USD
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	270428	shares
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	344319	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options may vest over a period not to exceed ten years. Stock options under our stock option plan may be awarded to officers, key-employees, consultants and non-employee directors of the Company. Under our stock option plan, every non-employee director of the Company is granted 7,000 options upon first taking office, and then 7,000 upon each additional year in office.
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2013Q2	loan	Share Based Compensation Expense ShareBasedCompensationExpense	5102	USD
CY2012Q2	loan	Share Based Compensation Expense ShareBasedCompensationExpense	4313	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.78
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.61
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	28000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	285000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	28000	shares
CY2013Q2	loan	Share Based Compensation Arrangement By Share Based Payment Award Vested And Non Vested Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndNonVestedOptionsOutstandingIntrinsicValue	147656	USD
CY2013Q2	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue	145858	USD
CY2013Q2	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableNumber	282000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.92
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.53
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.01
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.97
CY2013Q2	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice	0.97
	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term Outstanding Option ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermOutstandingOption	P1Y11M5D
	loan	Share Based Compensation Arrangement By Share Based Payment Award Option Weighted Average Remaining Contractual Term For Vested And Exercisable Options ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionWeightedAverageRemainingContractualTermForVestedAndExercisableOptions	P1Y10M28D
CY2011Q3	loan	Market Price Per Share On Date Of Restricted Shares Grant MarketPricePerShareOnDateOfRestrictedSharesGrant	1.21
CY2011Q3	loan	Restriction On Exercise Of Additional Options Held By Ceo Below Prescribed Exercise Price Limit RestrictionOnExerciseOfAdditionalOptionsHeldByCeoBelowPrescribedExercisePriceLimit	210000	shares
CY2011Q3	loan	Description Of Terms Of Restricted Shares Agreement DescriptionOfTermsOfRestrictedSharesAgreement	Until their expiration, Mr. Ran will be required to forfeit approximately 4.76 Restricted Shares for each share of Common Stock issued upon any exercise of the Remaining Options.
CY2013Q2	loan	Amount Of Personal Guarantee Provided By Related Party For Debt Borrowed AmountOfPersonalGuaranteeProvidedByRelatedPartyForDebtBorrowed	5000000	USD
CY2010Q4	loan	Senior Long Term Notes Under Private Placement SeniorLongTermNotesUnderPrivatePlacement	500000	USD
CY2010Q4	us-gaap	Loans Pledged As Collateral LoansPledgedAsCollateral	750000	USD
CY2010Q4	loan	Private Placement Offering PrivatePlacementOffering	5000000	USD
CY2010	loan	Number Of Warrants Issued To Underwriter NumberOfWarrantsIssuedToUnderwriter	20000	shares
CY2010Q4	loan	Exercise Price Of Warrants Issued To Underwriter ExercisePriceOfWarrantsIssuedToUnderwriter	2.50
CY2010	loan	Common Stock Issued To Underwriter Value CommonStockIssuedToUnderwriterValue	11683	USD
CY2010	loan	Maturity Term Of Warrants MaturityTermOfWarrants	P5Y
CY2010	loan	Senior Notes Maturity Date SeniorNotesMaturityDate	Dec 31 2013
CY2010	loan	Expiration Date Of Raising Of Capital ExpirationDateOfRaisingOfCapital	Mar 31 2011
CY2013Q2	loan	Amortization Of Senior Secured Notes Issuance Cost AmortizationOfSeniorSecuredNotesIssuanceCost	9099	USD
CY2011	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	80000	USD
CY2011Q4	loan	Amount Of Personal Guarantee Commitment Provided By Defendant AmountOfPersonalGuaranteeCommitmentProvidedByDefendant	5000000	USD
	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	80000	USD
CY2011	loan	Operating Leases Term Of Lease OperatingLeasesTermOfLease	P5Y2M

Files In Submission

Name	View Source	Status
0001144204-13-042077-index-headers.html	Edgar Link	pending
0001144204-13-042077-index.html	Edgar Link	pending
0001144204-13-042077.txt	Edgar Link	pending
0001144204-13-042077-xbrl.zip	Edgar Link	pending
ex10-1pg01.jpg	Edgar Link	pending
ex10-1pg02.jpg	Edgar Link	pending
ex10-1pg03.jpg	Edgar Link	pending
ex10-1pg04.jpg	Edgar Link	pending
ex10-2pg01.jpg	Edgar Link	pending
ex10-2pg02.jpg	Edgar Link	pending
ex10-2pg03.jpg	Edgar Link	pending
ex10-2pg04.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
loan-20130630.xml	Edgar Link	completed
loan-20130630.xsd	Edgar Link	pending
loan-20130630_cal.xml	Edgar Link	unprocessable
loan-20130630_def.xml	Edgar Link	unprocessable
loan-20130630_lab.xml	Edgar Link	unprocessable
loan-20130630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v350225_10q.htm	Edgar Link	pending
v350225_ex10-1.htm	Edgar Link	pending
v350225_ex10-2.htm	Edgar Link	pending
v350225_ex31-1.htm	Edgar Link	pending
v350225_ex31-2.htm	Edgar Link	pending
v350225_ex32-1.htm	Edgar Link	pending
v350225_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LOAN
Manhattan Bridge Capital Inc Stock $loan

2013 Q2 Form 10-Q Financial Statement

#000114420413042077 Filed on July 31, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN Manhattan Bridge Capital Inc Stock $loan

2013 Q2 Form 10-Q Financial Statement

#000114420413042077 Filed on July 31, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN
Manhattan Bridge Capital Inc Stock $loan